Fig. 2
From: Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age
Receiver operating curve comparisons for the discriminatory ability of EEAA and GrimAA between early relapse and late relapse status stratified by sex. Receiver operating curves for female (A) and male (B) patients. Model 1 evaluates the discriminatory ability of chronological age at first treatment and chemoimmunotherapy regimen. Model 2 evaluates the discriminatory ability of chronological age at first treatment, chemoimmunotherapy regimen, EEAA, and GrimAA. Area under the curve estimates for each model are provided in the figure legend